|
25 May 2021 |
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
|
|
20 May 2021 |
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
|
|
19 May 2021 |
Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb
|
|
18 May 2021 |
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases
|
|
14 May 2021 |
Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
|
|
12 May 2021 |
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
|
|
11 May 2021 |
Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
|
|
11 May 2021 |
Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders
|
|
05 May 2021 |
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy
|
|
04 May 2021 |
UPPTHERA and ComInnex sign research collaboration for the development of novel Proteolysis-Targeting Chimera candidates
|
|
29 Apr 2021 |
Pfizer Acquires Amplyx Pharmaceuticals
|
|
26 Apr 2021 |
Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
|
|
22 Apr 2021 |
Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing
|
|
21 Apr 2021 |
Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review
|
|
20 Apr 2021 |
Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia
|
|
20 Apr 2021 |
Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer
|
|
15 Apr 2021 |
New protein degradation centre to lead drug discovery revolution
|
|
14 Apr 2021 |
BERG Announces Oncology Pipeline Advancements And Biomarker Developments For Clinical Decision Support In Breast Cancer At AACR
|
|
09 Apr 2021 |
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
|
|
06 Apr 2021 |
Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
|
|
05 Apr 2021 |
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
|
|
02 Apr 2021 |
Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
|
|
02 Apr 2021 |
AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
|
|
02 Apr 2021 |
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
|
|
30 Mar 2021 |
Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001
|
